Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 472500
Key Takeaways
Risk factor
Modest price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Data is available to registered users only
Target Price
The average target price of 128940.KS is 364986 and suggests 24% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation
Data is available to registered users only
Buy
Sell